Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin

scientific article published on 01 June 1984

Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9378(84)90147-9
P698PubMed publication ID6539567

P50authorClaes Göran TropéQ17112916
Eva Cavallin-StåhlQ47451429
P2093author name stringG Horváth
H Christiansen
E Simonsen
J E Johnsson
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectdoxorubicinQ18936
cisplatinQ412415
endometrial adenocarcinomaQ18555221
P304page(s)379-381
P577publication date1984-06-01
P1433published inAmerican Journal of Obstetrics and GynecologyQ4744256
P1476titleTreatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin
P478volume149

Reverse relations

cites work (P2860)
Q33389952A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma
Q33835933Adjuvant chemotherapy for high-risk endometrial cancer
Q24246360Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
Q37560813Current status of molecular-targeted drugs for endometrial cancer (Review).
Q63199203Endometrial cancer
Q33541943Hormonal treatment of endometrial cancer.
Q33345872Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group
Q40877328Systemic treatment in disseminated endometrial cancer

Search more.